PASITHEA THERAPEUTICS CORP's ticker is and the CUSIP is 70261F103. A total of 9 filers reported holding PASITHEA THERAPEUTICS CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $181,240 | -70.8% | 282,437 | -42.6% | 0.03% | -60.6% |
| Q3 2022 | $620,000 | +24.7% | 491,797 | 0.0% | 0.07% | +29.1% |
| Q2 2022 | $497,000 | -30.5% | 491,797 | -10.6% | 0.06% | -11.3% |
| Q1 2022 | $715,000 | -26.5% | 550,000 | 0.0% | 0.06% | -3.1% |
| Q4 2021 | $973,000 | – | 550,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| K2 PRINCIPAL FUND, L.P. | 550,000 | $715,000 | 0.06% |
| MARK SHEPTOFF FINANCIAL PLANNING, LLC | 48,000 | $62,000 | 0.03% |
| TWO SIGMA SECURITIES, LLC | 18,899 | $25,000 | 0.00% |
| VANGUARD GROUP INC | 56,583 | $74,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 84 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| BlackRock Inc. | 9,962 | $13,000 | 0.00% |
| Citadel Advisors | 72,937 | $95,000 | 0.00% |
| JPMORGAN CHASE & CO | 1,000 | $1,000 | 0.00% |